Home 2018-07-18T12:14:50+00:00


At M4K Pharma, we are using open science to revolutionize how affordable new treatments are discovered and developed. Through our Medicines4Kids program, we will aggregate and align the work of global academics, foundations and industry researchers to advance new cures for childhood diseases not well-served by current business models.

M4K Pharma’s Data:
In line with M4K Pharma’s open science principles, we are committed to sharing our research data freely in the public domain. Our data is currently available for public viewing in the video recordings of our monthly open scientific updates, which are posted to our Blog and also available through our YouTube Channel. Data will be openly available in a downloadable format soon.

Ellie Williams @thesgconline crystallizes ALK3 and ALK6, two homologs of the #DIPG and #FOP target ALK2, with ALK2 inhibitors from @M4KPharma. #Openscience notebook record: https://t.co/CBXYHf3CtN Accompanying blog: https://t.co/Vf0m9iPyJK @DefeatDIPG @FOPFriends

And @MycetOS in partnership with @DNDi And @M4KPharma in partnership with @thesgconline https://t.co/Ez65WOdweF

Missed our Sept Scientific Update meeting? Listen to a recording of the meeting's discussions here: https://t.co/GR0PsxytDq

It's time to go all-in with open drug discovery! @M4KPharma @DNDi @O_S_M https://t.co/XHU5zPC3LE

The donated support that @M4KPharma and the #dipg community is getting from @CRiverLabs is absolutely phenomenal and heart-warming. Now, they're sharing with us their new chemistry ideas. @BrainTumourOrg @OICR_news #openscience #opendrugdiscovery @GenomeCanada @WellcomeOpenRes

Load More...

Latest Blog Posts